1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Relevant clinical and radiologic characteristics for 22 patients
No. Time to Arterial Puncture (h) Target Vessel Location Baseline NIHSS TICI Puncture to Recanalization Time (min) Intravenous rtPA (mg/kg)^a Hemorrhagic Event According to ECASS Classifications⁵ mRS at 90 Days
Pre Post
1 8.5 BA 23 0 2b 80 – None 1
2 3 Lt M1 24 0 2b 30 0.6 None 2
3 3 Rt M1 19 0 2b 15 0.6 None 1
4 4 BA 24 0 2a 80 0.6 Asymptomatic HI-2 5
5 4.5 Rt M1 16 0 2b 40 0.6 None 3
6 5.5 Rt ICA 16 0 2a 50 0.9 Asymptomatic HI-1 2
7 6 Rt. M1 14 0 2b 30 – None 0
8 2.5 Rt. M1 15 0 3 40 0.6 None 5
9 2.5 Lt ICA 21 0 3 25 0.6 None 6
10 6 Rt ICA 16 0 2a 60 0.9 None 3
11 5.5 Rt ICA 16 0 3 40 – None 3
12 4 BA 29 0 2a 60 – Asymptomatic HI-2 5
13 5.5 Lt M1 23 0 2b 50 0.9 None 6
14 4 Lt M1 11 0 3 60 0.6 None 4
15 8 BA 25 0 2b 50 – Symptomatic PH-2 6
16 7 Lt M1 20 0 3 15 0.6 Symptomatic PH-1 3
17 6 Rt M1 10 0 3 20 – None 0
18 6 Lt M1 12 0 2b 10 0.6 None 0
19 5.5 Rt M1 11 0 2b 30 – None 0
20 7 Lt M1 18 0 2b 50 – Asymptomatic HI-2 3
21 9 Lt M1 14 0 3 30 0.6 Asymptomatic HI-1 2
22 3 Lt M1 20 0 3 15 0.9 None 2
a – indicates dosage of rtPA.